Abeona Therapeutics Inc (ABEO)
Abeona Therapeutics Inc. (NASDAQ-ABEO) is a healthcare company in the biotechnology sector, and ABEO is its common stock listed on the NASDAQ exchange. The security context is common equity, meaning the instrument represents an ownership interest in the company rather than a fund, note, or other listed product. Abeona Therapeutics Inc. focuses on developing cell and gene therapy candidates for serious medical conditions, with programs aimed at inherited and rare diseases. Its work is centered on research and development rather than broad commercial product categories, so the stock reflects exposure to a clinical-stage biotechnology business.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-ABEO
|
$7.48
|
18.2% Upside
|
Undervalued
|
$19.71
|
211.4% Upside
|
Bargain
|
Good
|
—
|
—
|
—
|
0.0%
|
August 12, 2026
|
5.5x
|
2.5x
|
25.0x
|
369.3 M
|
218 M
|
5.9%
|
64.2%
|
-1.8
|
—
|
-128.9%
|
